TBPH – theravance biopharma, inc. - ordinary shares (US:NASDAQ)
Stock Stats
News
3/5
11:00 am
tbph
Low
Theravance Biopharma (TBPH) was downgraded by Oppenheimer Holdings, Inc. from "outperform" to "market perform".
3/4
08:00 am
tbph
Low
Theravance Biopharma (TBPH) had its "neutral" rating reaffirmed by B. Riley Financial, Inc.. They now have a $14.00 price target on the stock, down from $28.00.
3/4
07:43 am
tbph
Low
Theravance shuts down R&D efforts and cuts workforce by half after Phase III trial failure [Yahoo! Finance]
3/3
12:23 pm
tbph
Low
The Excruciating Failure That Could Cause Theravance, Down 27%, To Sell Itself [Yahoo! Finance]
3/3
12:16 pm
tbph
Low
Theravance Biopharma (TBPH) had its price target lowered by BTIG Research from $40.00 to $21.00. They now have a "buy" rating on the stock.
11/10/2025
04:05 pm
TBPH
22.7%
BEAT
8/12/2025
04:05 pm
TBPH
4.2%
BEAT
5/8/2025
04:05 pm
TBPH
-9.3%
MISS
3/5
12:58 pm
Downgrades
Outperform
Perform
Oppenheimer
Low
-0.7%
3/5
12:58 pm
Downgrades
Outperform
Perform
Oppenheimer
Low
-0.7%
3/5
11:00 am
Downgrades
Outperform
Market Perform
Oppenheimer Holdings, Inc.
Low
0.1%
3/5
10:36 am
Downgrades
OUTPERFORM
PERFORM
OPPENHEIMER
Low
0.1%
3/5
10:36 am
Downgrades
OUTPERFORM
PERFORM
OPPENHEIMER
Low
0.1%
3/3
08:35 am
tbph
High
Form 8-K Theravance Biopharma, For: Mar 03
2/24
07:44 pm
tbph
Low
Form 4 Theravance Biopharma, For: Feb 20 Filed by: Winningham Rick E
2/24
07:41 pm
tbph
Low
Form 4 Theravance Biopharma, For: Feb 20 Filed by: Sawaf Aziz
2/24
07:39 pm
tbph
Low
Form 4 Theravance Biopharma, For: Feb 20 Filed by: Miller Aine
2/24
07:37 pm
tbph
Low
Form 4 Theravance Biopharma, For: Feb 20 Filed by: Grimaud Brett A.
Show more
Top News Gainers
11/26 Theravance Biopharma to Present at Two Upcoming Investor Conferences 10.0%
4/9 Form 8-K Theravance Biopharma, For: Apr 09 5.1%
7/31 Q2/2019 6/30/2019 EPS -0.720 ZacksConsensus -1.220 ActVsEst 0.500 - Beat 4.8%
3/23 Stocks To Watch: Theravance Biopharma Sees Relative Strength Rating Jump To 94 [Investor's Business Daily] 4.7%
3/2 Theravance Biopharma Announces Closing of Private Placement of $400 Million Non-Recourse Notes 4.4%
4/20 Theravance Biopharma Announces Peer-Reviewed Publication Highlighting TD-1473 Program in the Journal of Crohn's and Colitis 4.1%
4/23 Theravance Biopharma Announces First Subject Dosed in Phase 1 Study of TD-0903, in Development for the Treatment of Hospitalized Patients with Acute Lung Injury Caused by COVID-19 3.9%
7/25 Theravance Biopharma to Report Second Quarter 2019 Financial Results on July 31 3.8%
11/6 Theravance Biopharma to Present at the 2019 Credit Suisse Healthcare Conference 3.6%
1/30 Theravance Biopharma Inc (NASDAQ: TBPH) was upgraded by analysts at BidaskClub from a "buy" rating to a "strong-buy" rating. 3.6%
Top News Decliners
2/11 Theravance Biopharma Announces Pricing of Public Offering of Ordinary Shares -11.5%
5/7 Theravance Biopharma, Inc. Reports First Quarter 2019 Financial Results and Provides Business Update -9.6%
4/30 Form 4 Theravance Biopharma, For: Apr 28 Filed by: YOUNG WILLIAM D -8.3%
9/25 Theravance Biopharma to Present at the 2019 Cantor Global Healthcare Conference -7.7%
2/10 Theravance Biopharma Announces Proposed Public Offering of Ordinary Shares -7.4%
3/24 Form DEF 14A Theravance Biopharma, For: Apr 28 -5.4%
4/29 Form 8-K Theravance Biopharma, For: Apr 28 -5.0%
5/22 Form 4 Theravance Biopharma, For: May 20 Filed by: WORBOYS PHILIP D -4.9%
6/14 Theravance Biopharma and Mylan Expand YUPELRI® (revefenacin) Development and Commercialization Agreement to Include China and Adjacent Territories -4.8%
5/18 Theravance Biopharma Inc (NASDAQ: TBPH) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. -3.8%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3